« Back to Malignant Tumors of the Skin

Malignant Melanoma

»What is melanoma?
»How common is malignant melanoma in the United States?
»What causes melanoma?
»What groups have a genetic predisposition to familial melanoma?
»List the risk factors for melanoma.
»List the high-risk groups for developing melanoma.
»Do all melanomas develop from atypical nevi?
»What are cancer stem cells?
»Is melanoma a single disease?
»What are the molecular pathways in melanoma?
»Is there a host immune response to melanoma?
»Describe the clinical appearance of melanoma.
»What are the ABCDEs of melanoma?
»What is dermoscopy?
»Where on the body does melanoma most commonly arise?
»Are there different types of melanoma?
»What are Clark’s levels?
»What is Breslow’s depth?
»What other findings should be reported in the histopathologic diagnosis of melanoma?
»What are the common immunohistochemical (IHC) markers utilized in the diagnosis of melanoma?
»Are there other factors with prognostic impact in patients with melanoma?
»How are patients with melanoma evaluated after the initial diagnosis?
»What is the most current system for staging melanoma?
»How is melanoma treated?
»How wide should surgical margins be?
»What is the most important risk factor for local recurrence of primary melanoma?
»Does a biopsy of melanoma increase the risk of spreading tumor cells or causing metastases?
»Describe the recommended follow-up for a patient with melanoma.
»Which tests or examinations are conducted during the routine follow-up of patients who have had melanoma?
»Does local tumor recurrence influence overall survival?
»What is elective lymph node dissection (ELND)? When is it indicated?
»What is sentinel lymph node biopsy? When is it indicated?
»What is linear melanonychia?
»What is Hutchinson’s sign?
»What is Hutchinson’s freckle?
»Are there any new ways to assess prognosis in patients with melanoma?
»What forms of chemotherapy are used in the treatment of metastatic melanoma?
»Is radiation therapy effective for melanoma?
»How effective is immunotherapy in malignant melanoma?
»Does gene therapy offer any better results?
»How about local perfusion?
»What are some newer targeted therapies for melanoma?

 
 
 

Are there other factors with prognostic impact in patients with melanoma?

The strongest predictors of prognosis are Breslow’s depth, presence of ulceration in the primary tumor, and presence of nodal disease. Secondary predictors of prognosis include the number of positive lymph nodes, extension of the tumor into extranodal soft tissue, age at time of diagnosis, sex (women >men), and anatomic site of primary tumor. In this regard, extremities, excluding the hands and feet, have the most favorable prognosis, while lesions on the scalp, hands, feet, and mucosal surfaces have the worst.

Balch CM, Seng-Jaw S, Gershenwald JE, et al: Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer Staging System, J Clin Oncol 19:3622–3634, 2001.

Mohr P, Eggermont AM, Hauschild A, Buzaid A: Staging of cutaneous melanoma, Ann Oncol 20(Suppl 6):vi14–vi21, 2009.